Vivos Therapeutics, Inc. (VVOS): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$1.49M
As of 2025-12-31
-$3.81M
As of 2026-06-30
$25.54M2019-12-31: -$2.94M2020-12-31: $16.92M2021-12-31: $25.54M2022-12-31: $4.80M2023-12-31: $411.0K2024-12-31: $7.95M2025-12-31: -$1.49M-$1.49M
2019-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$1.49Mn/m2026-04-15, Balance as of period end
2024-12-31$7.95Mn/m2026-04-15, Balance as of period end
2023-12-31$411.0K-91.4%2025-03-31, Balance as of period end
2022-12-31$4.80M-81.2%2024-07-30, Balance as of period end
2021-12-31$25.54M+51.0%2023-03-30, Balance as of period end
2020-12-31$16.92Mn/m2022-03-31, Balance as of period end
2019-12-31-$2.94Mn/a2021-03-25, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$1.49Mn/m
Nephros Inc (NEPH)2025-12-31$10.20M+18.8%
Profound Medical Corp. (PROF)2025-12-31$66.43M+10.0%
Biotricity Inc. (BTCY)2026-03-31-$34.68Mn/m
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$3.10M-29.8%
Spectral AI, Inc. (MDAI)2025-12-31-$5.73Mn/m
Allurion Technologies, Inc. (ALUR)2025-12-31-$77.19Mn/m
DarioHealth Corp. (DRIO)2025-12-31$67.92M-5.7%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$31.22M-21.5%

Compare VVOS, NEPH, PROF, BTCY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗